Moving diagnostics upstream: prehospital blood gas analysis is associated with safe community care and improved patient selection for hospital admission

This study demonstrates that integrating prehospital point-of-care blood gas analysis into physician-staffed emergency medical services significantly increases safe ambulatory treatment rates and improves patient selection for hospital admission through better risk stratification.

The Gist

Imagine the Emergency Department (ED) of a hospital as a busy airport terminal. It's designed for people who are in critical condition and need immediate, high-level care. But lately, this terminal is overcrowded. The runways are jammed, the gates are full, and the staff are exhausted. Many people arrive at the terminal who don't actually need a plane; they just need a taxi home or a quick check-up at a local clinic.

This study asks a simple question: What if we could check a passenger's "health passport" right at the gate, before they even get on the plane?

The Experiment: A Mobile Lab on Wheels

In the city of Jena, Germany, emergency doctors started carrying a mobile blood gas analyzer (a small, high-tech device that looks like a rugged tablet) in their ambulances.

• The Old Way: A doctor arrives, checks your pulse and blood pressure, and then makes a guess: "Do I need to take this person to the hospital, or can I treat them here?" It's like a pilot guessing the weather without a radar.
• The New Way: The doctor uses the device to get an instant "biochemical snapshot" of your blood. It tells them exactly how your body is handling oxygen, acid, and stress (specifically looking at a marker called lactate).

The Results: Better Decisions, Safer Trips

The researchers compared two groups of patients: those who got this extra blood test and those who didn't. Here is what they found, using our airport analogy:

1. Fewer Unnecessary Flights (The "Treat-at-Home" Boost)

• Without the test: Only about 9% of patients were treated safely at home. The doctors, playing it safe, often said, "Let's just take them to the hospital to be sure."
• With the test: That number jumped to 28%.
• The Analogy: The blood test acted like a confident security scanner. It gave the doctors the proof they needed to say, "Your health passport is clear; you don't need a plane. You can go home and rest." This is a fourfold increase in people being treated safely in their own communities.

2. Better Filtering for Those Who Do Fly (The "Admission" Boost)

• For the people who did need to go to the hospital, the test helped the doctors be more precise.
• Without the test: About 30% of people sent to the hospital ended up needing to be admitted (staying overnight).
• With the test: 58% of the people sent to the hospital were admitted.
• The Analogy: The test helped the doctors distinguish between a passenger who just needs a seat on the plane (a quick ER visit) and one who needs to be in the VIP lounge with a doctor watching them all night. It ensured that the hospital beds were reserved for the people who truly needed them.

3. Safety: No One Was Left Behind
The most important question was: "Did sending people home without a hospital visit make them sick later?"

• The Answer: No. In the group treated at home with the help of the blood test, zero people had to come back to the ER or call an ambulance again within 30 days.
• The Analogy: It's like a pilot saying, "We checked the engine, the fuel, and the weather. You are safe to fly home." And indeed, everyone arrived safely.

The "Magic Number": Lactate

The study found that one specific number in the blood test was the most helpful: Lactate.
Think of lactate as a "stress smoke alarm" in your body.

• If the alarm is low, the doctor knows you are likely fine to stay home.
• If the alarm is high (above 2.6), it's a red flag that your body is under serious stress, and you need to go to the hospital immediately.

Why This Matters

This study suggests that giving emergency doctors a "superpower" (instant blood data) helps them make smarter choices.

• For the Patient: You get treated faster, either at home or in the right hospital bed, without unnecessary stress.
• For the System: It clears the "airport terminal" (the ER) of low-risk passengers, so the staff can focus on the critical cases.

The Catch

The authors are careful to say this is a pilot study (a first draft). It was done in one city with a specific type of doctor-led ambulance. They need to test this in more places and with different teams (like paramedics) to make sure it works everywhere. But the results are promising: Objective data helps us stop guessing and start knowing.

Technical Summary

1. Problem Statement

Emergency Departments (EDs) in high-income countries are facing critical challenges, including rising patient volumes, workforce shortages, and severe overcrowding. Current prehospital Emergency Medical Services (EMS) often rely on basic monitoring (vital signs, history, and physical exam) to make disposition decisions (treat on-site vs. transport to ED). This lack of objective biochemical data limits the ability of physicians to confidently identify low-risk patients who can be safely treated in the community ("treat-and-refer") and accurately stratify high-risk patients who require hospital admission. Consequently, there is a tendency toward defensive medicine, leading to unnecessary transports and inefficient ED resource utilization.

2. Methodology

Study Design & Setting:

• Type: Retrospective observational study (non-interventional service evaluation).
• Location: Jena, Germany, within a physician-staffed EMS system.
• Period: July 2023 to May 2024.
• Intervention: Implementation of a mobile Point-of-Care (POC) Blood Gas Analysis (BGA) device (epoc Blood Analysis System) available to emergency physicians at the scene.

Participants:

• Intervention Group: 98 adult patients (≥18 years) who received prehospital BGA. Indications included acute dyspnea, hemodynamic instability, suspected sepsis, metabolic derangement, and altered mental status.
• Control Group: 390 patients from the same period who did not receive BGA.
• Matching: Propensity score matching (1:4 ratio) was used to balance the groups based on age, sex, NACA (National Advisory Committee for Aeronautics) severity score, and ICD-10 diagnostic category.

Data Collection & Outcomes:

• Primary Outcomes:
  1. Proportion of patients treated on-scene (ambulatory) without transport.
  2. Hospital admission rate among transported patients (ED conversion rate).
• Secondary Outcomes:
  1. Safety of ambulatory treatment (30-day follow-up for unplanned ED re-attendance or repeat EMS contact).
  2. Association between specific BGA parameters (pH, lactate, electrolytes) and disposition decisions.
• Statistical Analysis: Standardized mean differences for balance; Wilcoxon rank-sum and Fisher's exact tests for comparisons; Receiver Operating Characteristic (ROC) analysis for lactate thresholds; and multivariable logistic regression for robustness.

3. Key Contributions

• Shift in Diagnostic Paradigm: The study demonstrates the feasibility and impact of moving advanced diagnostics (BGA) from the hospital/ED setting directly into the prehospital environment.
• Objective Risk Stratification: It provides evidence that biochemical data (specifically lactate and acid-base status) significantly influences clinical decision-making, allowing for more confident "treat-and-refer" decisions.
• Safety Validation: It addresses the primary barrier to ambulatory care—safety concerns—by demonstrating that patients treated on-site with BGA support did not experience adverse events within 30 days.
• Resource Optimization: The study links prehospital diagnostics to improved ED resource allocation by reducing low-acuity transports and increasing the yield of necessary admissions.

4. Results

Cohort Characteristics:

• The 98 BGA patients were successfully matched to 390 controls with no significant differences in baseline demographics, NACA scores, or vital signs.

Primary Outcomes:

• Ambulatory Treatment: The BGA cohort had a significantly higher rate of on-scene treatment compared to controls (27.6% vs. 8.7%).
  • Odds Ratio (OR): 3.98 (95% CI 2.26–7.01; p<0.001).
• Hospital Admission (ED Conversion): Among patients who were transported, the admission rate in the BGA cohort was 58%, compared to a regional average of approximately 30%. This indicates that BGA helped filter out low-risk patients who would otherwise have been transported but not admitted.

Secondary Outcomes:

• Safety: 0% of the 27 patients treated ambulatory in the BGA cohort required unplanned ED re-attendance or repeat EMS contact within 30 days.
• BGA Parameters:
  • Lactate was the most influential parameter for decision-making.
  • A lactate threshold of ≥2.6 mmol/L was identified as the optimal cutoff for distinguishing patients requiring transport (Sensitivity 85%, Specificity 47%, AUC 0.66).
  • Elevated lactate and acid-base disturbances were strongly associated with transport and subsequent admission.
• Operational Impact: Scene time was longer in the BGA group (median 37.0 min vs. 28.5 min), reflecting the time required for testing, but this was offset by the reduction in unnecessary transports.

Subgroup Analysis:

• The effect was most pronounced in NACA 2 patients (OR 27.0) and those with metabolic presentations (OR 7.4), though these subgroups were underpowered.

5. Significance and Implications

• Clinical Practice: Prehospital BGA empowers emergency physicians to make data-driven decisions, reducing "defensive transport" (transporting patients out of caution rather than necessity) and increasing confidence in managing patients at home.
• Health System Efficiency: By identifying low-risk patients early, the EMS system can reduce ED crowding. Conversely, by identifying high-risk biochemical markers (like elevated lactate) early, it ensures that high-risk patients are prioritized for admission, improving the "yield" of ED visits.
• Policy: The findings support the integration of POC testing into EMS protocols as a strategy to rebalance care delivery toward community settings.
• Limitations & Future Work: The study is single-center, observational, and relies on physician discretion for BGA usage, which may introduce selection bias. The authors note that the physician-staffed EMS model in Germany may differ from paramedic-led systems. Future multicenter trials are needed to confirm generalizability, cost-effectiveness, and applicability to non-physician EMS providers.

Conclusion:
The study concludes that integrating mobile blood gas analysis into prehospital care is associated with a fourfold increase in safe ambulatory treatment rates and a twofold increase in the efficiency of hospital admissions, without compromising patient safety. This suggests that objective biochemical data is a critical tool for modernizing emergency care pathways.